Qing Shuo Zhang

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice
    Qing Shuo Zhang
    Oregon Stem Cell Center, Oregon Health and Science University, Portland, OR 97239, USA
    Cancer Res 68:1601-8. 2008
  2. ncbi Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol
    Qing Shuo Zhang
    Oregon Stem Cell Center, Department of Pediatrics, Oregon Health and Science University, Portland, OR, USA
    Blood 116:5140-8. 2010
  3. ncbi Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology
    Shaomei Wang
    Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States of America
    PLoS ONE 5:e9200. 2010

Detail Information

Publications3

  1. ncbi Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice
    Qing Shuo Zhang
    Oregon Stem Cell Center, Oregon Health and Science University, Portland, OR 97239, USA
    Cancer Res 68:1601-8. 2008
    ..The reduction in oxidative DNA damage in tempol-treated FA fibroblasts and mice suggests that its tumor-delaying function may be attributed to its antioxidant activity...
  2. ncbi Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol
    Qing Shuo Zhang
    Oregon Stem Cell Center, Department of Pediatrics, Oregon Health and Science University, Portland, OR, USA
    Blood 116:5140-8. 2010
    ..We conclude that Fancd2(-/-) mice have readily quantifiable hematopoietic defects, and that this model is well suited for pharmacologic screening studies...
  3. ncbi Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology
    Shaomei Wang
    Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States of America
    PLoS ONE 5:e9200. 2010
    ....